Stocks are up Tuesday, with the Dow Jones Industrial Average up 0.39%, the Nasdaq up 0.36% and the S&P 500 up 0.35%. Tuesday’s sole winner is in correction, while today’s losers include…
247sam The three major U.S. stock indexes opened lower this morning following weak economic data from Germany (more coverage here). The weekend meetings between Chancellor Angela Merkel and French President Francois Hollande highlighted…
Photo by Spencer Platt/Getty ImagesThe stock market is down Monday, with the Dow Jones Industrial Average down 0.13%, the Nasdaq down 0.50% and the S&P 500 down 0.18%. Monday’s winners include a…
Just over two weeks ago Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) reported a statistically significant improvement in the company’s bavituximab lung-cancer treatment. Shares jumped nearly 50% and eventually posted at more than two-year…
Paul Ausick The three major U.S. stock indexes opened lower this morning after a weekend of mixed news from Asia. China’s trade balance rose on falling imports and industrial production failed to meet estimates…
The three major U.S. stock indexes opened mixed this morning following a lower-than-expected increase in non-farm payrolls (more coverage here). In Asia and Europe, though, markets were higher for different reasons. Asian…
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) is surging on news updating its non-small cell lung cancer trial. The company said that interim results were presented from its 121 patient randomized, double-blind, placebo-controlled Phase IIb trial…
Jon C. Ogg Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) is a year-end winner in small-cap biotech and emerging pharma based upon hepatitis-C Phase II trial data. The preliminary data shows that antiviral activity and a positive safety…
Jon C. Ogg We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend.  This is broken down in drug…
We are just about to get the first round of abstracts from companies presenting data at this year’s American Society of Clinical Oncology meeting for 2009. At BioHealthInvestor.com we compiled a brief…
Alkermes (NASDAQ: ALKS) and Johnson & Johnson Pharmaceutical Research and Developed today submitted paperwork seeking approval of their partnership drug, RISPERDAL CONSTA, to be allowed for treatment of bipolar disorder chronic relapse.…
Bearingpoint (BE) Still dropping after loss earlier in the month. Down to $2.53 from 52-week $8.56. General Growth Properties (GGP) REIT stocks are getting killed. Falls to $41.93 from 52-week high of…
Novastar Finl Inc (NFI) Poor earnings and possible delisting. Drops to $1.72 from 52-week high of $127.20. Standard Pacific (SPF) Home builder. Down to $3.66 from 52-week high of $30.52. Fannie Mae…
Douglas A. McIntyre Dell (DELL) got another delisting warning yesterday. It has to file its financials on time, or risk being thrown off the exchange. Dell has gotten a number of these. but Nasdaq (NDAQ)…
Blackstone (BX) Investors still worry about slowing private equity and tax issues. Shares fall to $28.75 from post-IPO high of $38. American Home Mtg (AHM) Forecasts second quarter loss on delinquent mortagages.…
